Is natalizumab overshooting its rebound?
- PMID: 18362270
- DOI: 10.1212/01.wnl.0000306415.37679.5a
Is natalizumab overshooting its rebound?
Comment on
-
Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients.Neurology. 2008 Mar 25;70(13 Pt 2):1150-1. doi: 10.1212/01.wnl.0000265393.03231.e5. Epub 2007 Sep 13. Neurology. 2008. PMID: 17872364 Clinical Trial. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical